PRKAA1 and fatty liver disease: Reduced body weight gain and fat mass accumulation, reduced liver steatosis, inhibited whitening of brown adipose tissue, prevented mitochondrial dysfunction, reversed the effect of the high-fat diet on the level of hepatic p-AMPK and SIRT1